19
https://pubmed.ncbi.nlm.nih.gov/38091831
Arachidonic acid treatment alleviates type 1 diabetes in NOD mice by reducing hyperglycemia, insulitis, and improving cytokine profiles, suggesting a potential novel therapeutic option.